- Lobbying
- Lobbying by Ultragenyx Pharmaceutical
Lobbying Relationship
Bills mentioned
H.R.925: The Heroes Act
Sponsor: Mike Thompson (D-Calif.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Steven Palmer | Legislative Assistant, Congressman Allard, 1991 - 1994; Associate, House Budget Committee, 1994 - 1995 |
Derrick White | Deputy Communications Director, Senator Orrin Hatch, 2000 - 2001 |
Jeff Sadosky | Communications Director, Senator Rob Portman, 2010 - 2013; Communications Director, Senator Kay Bailey Hutchison, 2008 - 2010; Press Secretary, Senator Mike DeWine, 2005 - 2006 |
Barrett Thornhill | Legislative Assistant, Sen. Mike Crapo (2003-2006); Legislative Assistant, Rep. Pat Toomey (2002-2003); Legislative Assistant, Rep. Charlie Norwood (2001-2002) |
Libby Greer | Chief of Staff, Rep. Allen Boyd (2001-2009) |
Cindy Brown | Chief of Staff, Rep. Ron Kind (2003-2009); Legislative Director, Rep. Ron Kind (1999-2002) |
Paul Dioguardi | Director, Office of Intergovernmental and External Affairs, U.S. Dept. of Health and Human Services (2009-2015); Chief of Staff, Office of Congressional and Intergovernmental Affairs, U.S. Dept. of Labor (1999-2001) |
Taylor Mason | Communications Director, Rep. David Young (2017) |
Michael Williams | Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Brian Jones (2019); Legislative Correspondent, Sen. Brian Jones (2018-2019) |
Kristina Dunklin | Legislative Director, Rep. Susan Brooks (2018-2019); Legislative Director, Rep. David Valadao (2015-2018); Legislative Assistant, Rep. David Valadao (2014-2015) |
Arthur Sidney | LD & Chief Counsel, Rep. Jackson Lee (2008-2009); Chief of staff and chief counsel, Rep. Johnson (2009-2020) |
Edward Reno III | n/a |
Zachary Williams | n/a |
Jeff Strunk | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to prescription drug pricing..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate